Hope Through Research
2017 MDA Scientific Conference - Overview
The 2017 MDA Scientific Conference will bring together influential professionals in the academic, government, industrial and clinical arenas who work in various ways to help drive scientific and therapeutic advancements and discoveries. The conference will focus on better understanding disease causes, identifying new therapeutic targets and innovative technologies and discussing new advances in preclinical and clinical research — all aimed at accelerating drug development and targeted treatments for neuromuscular diseases.
Early-Bird Registration Date: Feb. 10, 2017
Registration Deadline: Feb. 28, 2017
Conference presentations and discussions will focus on the following areas:
- Genetics, epigenetics and gene discovery
- Approaches to precision medicine
- Understanding nuclear membranes and protein misfolding/turnover
- Gaining insights into channelopathies, dystrophin glycocomplex diseases, mitochondrial myopathies, repeat expansion diseases
- Motor and peripheral neuron diseases, and
- Clinical trials
Nearly 450 leaders in the neuromuscular field are expected to gather for this prestigious conference to share critical updates on a wide range of scientific topics. The conference facilitates multiple opportunities for the exchange of ideas and dialogue, and includes two evening poster sessions.
Become a Scientific Conference Sponsor
There are numerous ways to partner with MDA to reach the influential research community and help us drive progress that will fit your company’s needs and goals. To learn more, please contact us at email@example.com.
“The MDA Scientific Conference brings researchers from all over the world together to share their data, to exchange ideas and to establish new ideas for moving forward and developing new research projects. It also helps us determine how to take the results from basic studies and start translating them into clinical endeavors. There are not many opportunities to bring so many people together at the same place to share ideas … and it really generates new ideas for how to bring new treatments into the clinic.”
— Jeffrey Chamberlain, University of Washington in Seattle and member of MDA’s Research Advisory Committee